Sato Wataru, Horie Yasuo, Watanabe Sumio, Suzuki Akira
Department of Gastroenterology, Akita University School of Medicine.
Nihon Rinsho. 2005 Aug;63(8):1475-83.
Although hepatic steatosis had been considered to be a benign condition that does not deteriorate to either liver cirrhosis or hepatocellular carcinoma (HCC). Non-alcoholic steatohepatitis (NASH) is notable disease that has similar pathological features to alcoholic liver injury and progresses to liver cirrhosis and HCC. But the molecular mechanism for the onset of NASH, and for the transformation from steatosis to carcinogenesis are still unclear. Hepatocyte-specific PTEN deficient mice, we generated, have similar histological features to the patients of human NASH. These hepatocytes showed enhanced lipid accumulation, inflammatory change, and hyperoxidation. Moreover, they developed into HCC. Thus, impairment of PI3K/PTEN signaling may possibly be involved in a part of NASH/HCC cases in human.
尽管肝脂肪变性一直被认为是一种良性病症,不会恶化为肝硬化或肝细胞癌(HCC)。非酒精性脂肪性肝炎(NASH)是一种值得关注的疾病,它具有与酒精性肝损伤相似的病理特征,并会发展为肝硬化和HCC。但是,NASH发病以及从脂肪变性转变为致癌的分子机制仍不清楚。我们构建的肝细胞特异性PTEN缺陷小鼠具有与人类NASH患者相似的组织学特征。这些肝细胞表现出脂质蓄积增强、炎症变化和过氧化增加。此外,它们还发展成了HCC。因此,PI3K/PTEN信号通路的损伤可能在部分人类NASH/HCC病例中发挥作用。